| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2400086012 |
Affiliated Hospital of Guangdong Medical University |
gastric cancer |
Diagnostic Accuracy Test |
Post-market |
2025-05-12 | 82 | Patient list |
| ChiCTR2400086012 |
Affiliated Hospital of Guangdong Medical University |
gastric cancer |
Therapy Study |
Post-market |
2025-05-05 | 134 | Patient list |
| 212547 |
Shanghai Changzheng Hospital; Shanghai Dongfang Hospital |
gastric cancer |
Therapy Study |
Post-market |
2024-11-18 | 402 | Patient list |
| ChiCTR2200066893 |
Lanzhou University Second Hospital |
gastric cancer |
Therapy Study |
|
2024-08-26 | 397 | Patient list |
| ChiCTR2200064855 |
Wuwei Cancer Hospital of Gansu Province |
early gastric cancer |
Diagnostic Accuracy Test |
Post-market |
2023-10-23 | 313 | Patient list |
| 待审核 |
Clinical observation of Weizhuanan in the treatment of precancerous lesions of gastric cancer Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine |
Precancerous lesion of gastric cancer |
Therapy Study |
Post-market |
2022-06-19 | 876 | Patient list |
| ChiCTR2100049352 |
Clinical trial of RNF180/Setpin9 Gene methylation Detection Kit (PCR fluorescent probe method)
|
gastric cancer |
Diagnostic Accuracy Test |
Post-market |
2021-07-26 | 1126 | Patient list |
| 暂无 |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
malignant ascites in gastric cancer |
Therapy Study |
Post-market |
2021-05-05 | 1324 | Patient list |
| ChiCTR2100043363 |
|
Gastric cancer |
Diagnostic Accuracy Test |
|
2021-02-09 | 1290 | Patient list |
| ChiCTR2000041277 |
Chongqing University Cancer Hospital |
Transverse colon cancer, stomach cancer, liver cancer, kidney cancer |
Therapy Study |
Post-market |
2020-12-12 | 1388 | Patient list |